The kit generates real-time ready first strand cDNA from viral RNA or total RNA and owes much of its high performance to the TransAmp™ buffer. This novel buffer includes a highly optimized blend of random and anchored oligo(dT) primers, to ensure RNA is accurately represented without bias in the generated cDNA. Furthermore, it is designed to overcome challenging secondary structures in a 42oC reaction, which is the optimal temperature for the new enzyme. Similar to SensiFAST™ real-time kits, the cDNA synthesis kit is both sensitive and fast, producing a valid representation of low copy RNA transcripts in a rapid 30 minute protocol.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian’s diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, diagnostics manufacturers and biotech companies in more than 60 countries around the world. The Company’s shares are traded on NASDAQ’s Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
For more information about Bioline, please visit www.bioline.com
For more information about
For more information about
Most Popular Stories
- Chinese May Have Spotted Malaysia Airlines Debris
- Obama, Ukraine Discuss Russian Incursion in Crimea
- Social Media Causee Sleep Deprivation in Students
- First-time Jobless Claims Drop Unexpectedly
- General Electric Plans IPO of Credit Card Unit
- SXSW Crash Kills 2, Injures 23
- First-time U.S. Jobless Claims Hit 3-month Low
- Why Buffett Bets Big on Green Energy
- U.S. Business Inventories Up, Retail Sales Down
- 'Candy Crush' Maker Files IPO